Brandywine Global Investment Management LLC bought a new position in shares of RTI Surgical, Inc. (NASDAQ:RTIX) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 31,206 shares of the medical equipment provider’s stock, valued at approximately $183,000. Brandywine Global Investment Management LLC owned 0.05% of RTI Surgical at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Cigna Investments Inc. New bought a new position in RTI Surgical in the second quarter worth about $105,000. Citigroup Inc. raised its stake in RTI Surgical by 2,850.1% in the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 20,435 shares in the last quarter. First Quadrant L P CA bought a new position in RTI Surgical in the second quarter worth about $137,000. Thompson Davis & CO. Inc. raised its stake in RTI Surgical by 138.8% in the second quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 14,577 shares in the last quarter. Finally, American International Group Inc. raised its stake in RTI Surgical by 7.0% in the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 2,327 shares in the last quarter. Institutional investors own 69.99% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “31,206 Shares in RTI Surgical, Inc. (RTIX) Purchased by Brandywine Global Investment Management LLC” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://sportsperspectives.com/2017/10/12/31206-shares-in-rti-surgical-inc-rtix-purchased-by-brandywine-global-investment-management-llc.html.
A number of equities analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th. BidaskClub downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th.
Shares of RTI Surgical, Inc. (NASDAQ:RTIX) opened at 4.70 on Thursday. The company’s market cap is $277.46 million. RTI Surgical, Inc. has a 12 month low of $2.50 and a 12 month high of $6.00. The company’s 50 day moving average is $4.58 and its 200 day moving average is $4.84.
RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.02 EPS for the quarter, hitting the consensus estimate of $0.02. The firm had revenue of $72.10 million during the quarter, compared to analyst estimates of $70.25 million. RTI Surgical had a negative net margin of 6.53% and a positive return on equity of 2.07%. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, equities research analysts predict that RTI Surgical, Inc. will post $0.06 EPS for the current fiscal year.
In related news, EVP John N. Varela purchased 12,000 shares of the business’s stock in a transaction on Friday, August 11th. The shares were acquired at an average price of $4.85 per share, for a total transaction of $58,200.00. Following the purchase, the executive vice president now owns 47,998 shares of the company’s stock, valued at approximately $232,790.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nicholas J. Valeriani purchased 5,500 shares of the business’s stock in a transaction on Monday, August 21st. The shares were bought at an average price of $4.70 per share, for a total transaction of $25,850.00. Following the purchase, the director now directly owns 47,754 shares in the company, valued at approximately $224,443.80. The disclosure for this purchase can be found here. Insiders own 4.90% of the company’s stock.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.